Home/Replicate Bioscience/Kathy Fernando, Ph.D.
KF

Kathy Fernando, Ph.D.

Chief Business Officer

Replicate Bioscience

Replicate Bioscience Pipeline

DrugIndicationPhase
srRNA Vaccine for HIVHIV PreventionPre-clinical
srRNA Vaccine for MalariaMalaria PreventionPre-clinical
Undisclosed Oncology ProgramOncologyPre-clinical
Undisclosed Autoimmune ProgramAutoimmune DisorderPre-clinical